IOSE-80 Cells

The IOSE-80 cell line is a non-tumorigenic cell line derived from normal human ovarian surface epithelium. It serves as a critical control in studies investigating ovarian cancer, as it provides a baseline to compare the behavior of cancerous cells. IOSE-80 cells have been utilized in research exploring the differential expression of genes in normal versus cancerous ovarian tissue. For instance, studies comparing IOSE-80 with ovarian cancer cell lines such as SKOV-3 and COC1 have identified significant upregulation of specific genes related to immunity and ferroptosis in cancerous cells, demonstrating distinct molecular profiles.

One notable characteristic of IOSE-80 cells is their response to various treatments and experimental conditions aimed at understanding mechanisms of proliferation and drug resistance in cancer cells. These cells have been employed as a control to assess the cytotoxicity of compounds and to evaluate the selective anti-cancer effects of agents. For example, flavonoid compounds like myricetin have been shown to inhibit proliferation and induce apoptosis in ovarian cancer cell lines while exhibiting no significant cytotoxic effects on IOSE-80 cells, indicating the non-cancerous nature and resilience of the IOSE-80 line.

Overall, IOSE-80 is a valuable model for studying the baseline behavior of healthy ovarian epithelial cells and serves as a comparative reference in understanding the changes that lead to malignancy in ovarian cancer. This makes it integral to research on novel treatments, drug screening, and investigations into the molecular mechanisms underpinning ovarian cancer development.